Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion

Accelerated partial breast irradiation (APBI) for patients with ductal carcinoma in situ (DCIS) is controversial, and the suitability criteria from the American Brachytherapy Society (ABS), American Society of Therapeutic Radiology and Oncology (ASTRO), and the European Society for Radiotherapy and Oncology (GEC-ESTRO) have important differences.

Source: Brachytherapy - December 11, 2020 Category: Cancer & Oncology Authors: Matthew N. Mills, Nicholas W. Russo, Ronica H. Nanda, Jason P. Wilson, Taghrid A. Altoos, Debra L. Caldwell, Lisa L. Stout, Scott Dube, Peter W. Blumencranz, Kathleen G. Allen, Roberto Diaz Source Type: research